Chapter 176 - Hemodialysis access - complex Flashcards

1
Q

Rate of access creation outside of the upper extremity

A

7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Patency of central venous angioplasty or stenting 1 year

A

29% angioplasty

70% stenting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Autogenous femoral vein transposition requirements

A

1) vein > 3mm
2) patent noncalcified fempop artery
3) No significant obesity of the thigh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Prosthetic loop fem-fem access requirements

A

1) patent FV, noncalcified SFA CFA

2) No obese patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prosthetic chest wall access requirements

A

1) patent axillosubclavian artery and vein

2) patent central vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tunnelled dialysis catheter requirement

A

Patent central vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hemoaccess reliable outflow vascular access device requirement

A

1) guide wire access to patent central vein
2) brachial artery > 3 mm
3) no active infection
4) SBP > 100 mmHg
5) EF > 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GSV forearm translocation secondary patency at 1 and 2 years

A

50-96% 1 year

66-84% 2 year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Infection rate of GSV forearm translocation

A

4%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

FV translocation patency and issues

A

67-100% secondary patency at 18 months

Steal at 27%

DRIL using contralateral GSV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Arm composite autogenous vascular access (ACAVA)

A

GSV and FV both used to limit steal

81% secondary patency at 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Brachial vein tranposition secondary patency

A

1 year 40-92%

2 year 55%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GSV transposition key points

size necessary
delay before cannulation

A

1) skip incisions or endoscopic harvest to reduce morbidity
2) > 3mm needed
3) cannulation after 6 weeks
4) not useful if morbidly obese

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

FV transposition issues

A

32% limb ischemia

ABI drop 0.21

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Primary and secondary patency of FV transposition

A

91%
84%
2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

FV transposition key points

A

1) 5 mm anastomosis
2) ABI > 0.85
3) palpable pedal pulse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Types of chest wall/cervical AV access

A

1) Axillary-ipsilateral axillay loop
2) Necklace: axillary-contralateral axillary/jugular loop
3) brachial-jugular

18
Q

Necklace access first described by

A

McCann 1996

19
Q

Necklace access patency

A

Primary 72%
Secondary 89%

1 year

20
Q

Brachial jugular access tunnelling track

A

Ventral aspect of shoulder

Over mid clavicle

21
Q

Brachial jugular access patency

A

70-93% secondary patency 2 year

22
Q

Rate of steal in chest wall access

A

0

even if previous forearm steal

23
Q

Rate of infection in chest wall access

A

4-15%

better than LE

24
Q

Tunnelling axillary axillary loop key points

A

1) reverse trendelenburg to keep breast in dependent position
2) Counterincision cephalic to areola
3) venous limb placed laterally
4) venous limb parallel to vein
5) arterial limb perpendicular to artery
6) access 2-3 weeks

25
HeRO graft components
1) graft: 6 mm PTFE with titanium coupler | 2) venous outflow 19F silicone catheter with nitinol braid
26
HeRO graft key points
1) counterincision in deltopectoral groove | 2) use in catheter-dependent patients with central venous stenosis/occlusion
27
HeRO patency 1 year and steal rate
Primary 22% Secondary 59% Steal 6.3%
28
Super HeRO adapter
Allow connection to an early cannulation graft (Accuseal
29
LE prosthetic AV access types
1) Fem-GSV 2) fem vein loop 3) popliteal -GSV 4) fem vein straight AV access
30
patency of LE prosthetic AV access
1 year 71% 2 year 60% secondary patency
31
Infection rate of LE prosthetic AV access
8-41%
32
Rate of limb loss in LE prosthetic AV access
1-3%
33
General orientation of LE grafts
Arterial limb lateral | Venous limb medial
34
Unconventional chest or abd wall access procedures
1) Bypass to right atrial appendage through 3rd intercostal space (minipericardiotomy) 2) right SFA-SVC prosthetic access 3) femoral transposition with iliac vein to SVC bypass 4) axillary artery to left renal vein 5) external iliac to left renal vein 6) right axillary artery to right atrium
35
Arterial-arterial access procedures
1) Axillary-axillary PTFE 2) femoral-femoral PTFE 3) SFA-PFA PTFE
36
Salgado SFA transposition for vascular access steps
1) transection of sartorius 2) mobilize SFA 3) close subcutaneous tissue beneath artery with sartorius 4) close skin over artery
37
Issues with arterial-arterial access
1) no medication infusion 2) pressure 20 min for bleeding to stop 3) low flow only to avoid recirculation and arm pain
38
Unconventional tunnelled dialysis catheters
1) transthoracic SVC catheter (hemothorax/pneumothorax) 2) Inside-out central venous access technique (IOCVA) 3) translumbar IVC catheters 4) transhepatic IVC catheter
39
Preferred renal replacement in pediatric population (< 20kg)
1) renal transplant | 2) PD
40
Rate of kidney transplant in pediatric patient with ESRD
38% in 1 year